In conclusion, a significantly greater number of participants supplemented with GinsengPlus had reductions in three CVD risk factors (LDL-C, HDL-C and SBP) compared to placebo a population with cholesterol levels above optimal. Participants supplemented with GinsengPlus had significant reductions in serum LDL-C from baseline at 8 weeks which was maintained to 12 weeks. Forty-two percent of participants with borderline high levels of LDL-C at baseline had reductions in CVD risk factors when supplemented with GinsengPlus.
Download the Full Clinical Study Report Link https://farlong.com/GinsengPlus.pdf